Simple test screens for colon cancer
Deaths fall 40% in British study
LONDON — A five-minute colon cancer test could reduce the number of deaths from the disease by about 40 percent, a new study says.
British researchers followed more than 170,000 people for about 11 years. Of those, more than 40,000 had a “flexi-scope’’ test, an exam that removes polyps, small growths that could become cancerous.
The test involves having a pen-size tube inserted into the colon so that doctors can identify and remove small polyps. Researchers used the test on people in their 50s. In the United Kingdom, government-funded colon cancer screening doesn’t start until age 60.
Researchers compared those results to more than 113,000 people who were not screened. They found the flexi-scope test reduced people’s chances of getting colon cancer by one third. It also cut their chances of dying by 43 percent. Researchers said the test needed to be done just once in a person’s lifetime.
The results were published online yesterday in the medical journal Lancet. The research was paid for by Britain’s Medical Research Council, National Health Service Research & Development, Cancer Research UK, and KeyMed.
Doctors said the findings might cause authorities to reconsider how they look for colon cancer. Worldwide, the disease causes 1 million cases and 600,000 deaths every year.
In Britain, people ages 60 to 74 are tested every other year with a fecal blood test. In the United States, colonoscopies — 20-minute scans of the entire colon that require sedation — are common, even though no trials have proved they work for cancer screening. Use of the flexi-scope test has plummeted in the United States because colonoscopies are perceived as being better.
To find polyps or to detect cancer early, the American Cancer Society recommends several options for people over 50: a flexi-scope test, double-contrast barium enema, or virtual colonoscopy every five years; or a colonoscopy every 10 years.
“It’s not for me to tell governments what to do,’’ said Dr. Wendy Atkin, a professor of surgery and cancer at Imperial College London, who led the research. “But this is a very big effect, with a very quick and a very cheap test.’’
Atkin said the test needs to be done only once because polyps that grow in the bowel appear before age 60 — so any potentially cancerous growths should be caught for people in their 50s. But the test works only on the lower bowel, so other exams, like the fecal blood test, would still be necessary.
Dr. David Ransohoff of the departments of medicine and epidemiology, University of North Carolina at Chapel Hill, said the Lancet findings might make doctors rethink whether the less-invasive flexi-scope test to scan the lower bowel, plus a highly sensitive fecal blood test to scan the upper bowel, could be better than a colonoscopy. Ransohoff was not linked to the study.
Ransohoff said further follow-up was necessary.
Dr. Durado Brooks of the American Cancer Society said he “would hope clinicians look at this information and recognize there is some value in this test.’’